GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA
Delisted
GRNA was delisted on the 21st of July, 2023.
60 hedge funds and large institutions have $44.4M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
60
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.48M | |
| 2 | +$633K | |
| 3 | +$559K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$287K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$272K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$1.75M | |
| 3 | -$420K | |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
-$237K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$82.4K |